NeuroGenomeX, Inc.

Board of Directors & Management Team

Arthur B. Calcagnini, Sr. Chairman of the Board

Mr. Calcagnini received his Bachelors Degree in Economics from Georgetown University in 1954 and was honorably discharged from the United States Army as 1st Lt., Infantry in 1956. He was President and CEO of Amerop Corporation, an international agribusiness firm specializing in the sugar industry. He was recruited to serve in the Nixon/Ford Administration as Director, Sugar Policy for the US Department of Agriculture. Subsequently he received a Presidential Commendation from President Reagan for his work in private sector trade initiatives in developing countries. He is the founder and retired owner of Lombard World Trade, Inc., a New York –based commodities trade house.

He is the former Chair of the Board of Regents and a two-term member of the Board of Directors of Georgetown University. He is a recipient of the John Carroll Award, the highest recognition given to Georgetown Alumni.

Mr. Calcagnini is a member of the Board of the Jupiter Hospital Medical Center Foundation in Jupiter, Florida and is currently involved in a wide range of philanthropic activities and private investments.

Jacqueline S. Doeler, CFA, President and Director

Ms. Doeler spent over 20 years working for the State of Wisconsin Investment Board (SWIB). SWIB is the state agency that manages the pension fund for Wisconsin state teachers and public employees. It is the ninth largest public pension fund in the country. Ms. Doeler held numerous positions at SWIB including Managing Director of Equities, Senior Portfolio Manager for a Healthcare Sector Portfolio, Assistant Portfolio Manager and Equity Analyst. Much of Ms. Doeler's career has been spent following and analyzing companies and industries within the healthcare sector. Ms. Doeler received a Bachelor of Arts from Purdue University and a Masters of Business Administration from the University of Wisconsin-Madison.

Thomas P. Sutula, MD, PhD, Founder, Chief Technical Officer and Director

Dr. Sutula is the Detling Professor and Chairman, Department of Neurology at the University of Wisconsin, a position he has held since 1995. He has also served as the Director for the Center for Neuroscience at the University of Wisconsin from 2000 - 2012. From 1984–1995 he was the Director of the Comprehensive Epilepsy Program and Director of Electroencephalography at the University of Wisconsin Hospital. He maintains an active basic research program as well as a clinical practice specializing in seizure disorders. Dr. Sutula's work in neural plasticity and epilepsy has attracted international attention, and he is regarded as an authority on neural plasticity associated with epilepsy and memory disorders.

Dr. Sutula has published over 180 scientific papers and abstracts in peer–reviewed journals on topics of neural plasticity, epilepsy, and neurology, and has edited 2 books in neurology including studies on the long-term damaging effects of seizures. He has served on numerous national scientific committees, editorial boards, and contributes regularly to scientific reviews and in national and international meetings. Dr. Sutula is board certified in internal medicine, neurology and psychiatry. He is active in professional societies including the Society for Neuroscience, the American Epilepsy Society, the American Neurological Association, and the American Academy of Neurology. He served as President of the American Epilepsy Society in 2002, and in 2009 received the Lennox Award of the American Epilepsy which is the highest career award of the society for contributions to understanding and treatment of epilepsy. In 2011 he received the Shaffrey Award of St. Joseph’s University in recognition of outstanding career service and achievement in the medical profession. He received an AB in Chemistry magna cum laude from Princeton University in 1971, an MD from the University of Pennsylvania in 1975, and a PhD in Neuroscience from the University of Virginia Medical School in 1985. He has received numerous academic honors including Phi Beta Kappa, Sigma Xi, and Alpha Omega Alpha.

William Checovich, PhD, COO and Director

Dr. Checovich has been a member of the Board since 2008. He is currently a Director of Operations at Illumina Corporation. Prior to joining Illumina, Dr. Checovich was Director of Commercial Operations for BioSentinel, Inc. and Director & Entrepreneur-in-Residence of the Coulter Medical Device Translational Research Incubator at the University of Wisconsin-Madison. From 2006 to 2008 he served as president of Caden Biosciences, a drug discovery company, and was previously the Director of Operations for Invitrogen Corporation's (now Thermo Fisher) Drug Discovery Solutions business unit. Dr. Checovich has held numerous roles in manufacturing, operations, product development, R&D, licensing, commercialization, and M&A.

Dr. Checovich received his Ph.D. in Biochemistry from the UW-Madison and completed post-doctoral training in the UW Departments of Medicine & Biomolecular Chemistry.

Eric Propper, CFA and Director

Mr. Propper is president and chief operating officer of Atlantic Trust, with more than 31 years of industry experience. He serves on the firm's Operating, Asset Allocation and Multi-Manager Investment committees. He is also a senior relationship manager and head of Atlantic Trust's New York office. In these roles, Mr. Propper oversees a team of investment and client service professionals and provides comprehensive portfolio and wealth management for high net worth individuals, families, foundations and endowments. He joined the firm in 1998 from J. Bush & Co., previously spending 10 years with Shearson Lehman Brothers and E.F. Hutton & Co. Mr. Propper earned a Bachelor of Arts from Hobart College and a Master of Business Administration from Columbia University. Mr. Propper also holds the Chartered Financial Analyst designation and is a member of the Stamford Society of Security Analysts. He serves on the Parents Advisory Committee for his alma mater Choate Rosemary Hall. He also served as a trustee for the Long Wharf Theatre in New Haven, Connecticut.